Administration of AZD2811 only on Day 1 of each cycle (rather than on Days 1 and 4) was implemented alongside the addition of G-CSF prophylaxis with the aim of managing recovery from neutropenia and improving patient convenience, and may also facilitate potential combinations with other treatments in future studies. Here, CSF3 is linked to Decreased total neutrophil count.